Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNYNF) Assets (2016 - 2025)

Historic Assets for Sanofi (SNYNF) over the last 17 years, with Q4 2025 value amounting to $147.6 billion.

  • Sanofi's Assets rose 402.56% to $147.6 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $147.6 billion, marking a year-over-year increase of 402.56%. This contributed to the annual value of $143.3 billion for FY2025, which is 29.9% down from last year.
  • According to the latest figures from Q4 2025, Sanofi's Assets is $147.6 billion, which was up 402.56% from $151.7 billion recorded in Q3 2025.
  • In the past 5 years, Sanofi's Assets ranged from a high of $151.7 billion in Q3 2025 and a low of $129.3 billion during Q4 2022
  • For the 5-year period, Sanofi's Assets averaged around $138.8 billion, with its median value being $138.1 billion (2021).
  • In the last 5 years, Sanofi's Assets skyrocketed by 710606.35% in 2021 and then crashed by 600.9% in 2022.
  • Over the past 5 years, Sanofi's Assets (Quarter) stood at $137.6 billion in 2021, then dropped by 6.01% to $129.3 billion in 2022, then rose by 5.24% to $136.1 billion in 2023, then increased by 4.29% to $141.9 billion in 2024, then increased by 4.03% to $147.6 billion in 2025.
  • Its Assets was $147.6 billion in Q4 2025, compared to $151.7 billion in Q3 2025 and $141.4 billion in Q2 2025.